EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Diagnostic, prognostic, and therapeutic potentials of gut microbiome profiling in human schistosomiasis: A comprehensive systematic review

Martin Gael Oyono, Sebastien Kenmoe, Jean Thierry Ebogo Belobo, Leonel Javeres Mbah Ntepe, Mireille Kameni, Leonel Meyo Kamguia, Thabo Mpotje, Justin Komguep Nono iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012844 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Martin Gael Oyono und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Infectious Diseases and Immunology, Institute of Medical Research and Medicinal Plant Studies (IMPM), Ministry of Scienti…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Schistosomiasis. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several studies have highlighted alteration in the gut microbiome associated with the onset and progression of diseases. Recognizing the potential of gut microbiota as biomarkers, this systematic review seeks to synthesize current data on the intricate relationship between the host gut microbiome profiles and their usefulness for the development of diagnostic, prognostic and therapeutic approaches to control human schistosomiasis.

Methods

A systematic literature review was carried out by searching for relevant studies published until date, that is May 2024, using Medline, Embase, Global Health, Web of Science, and Global Index Medicus databases. The keywords used to select articles were "Gut microbiome", "Gut Microbiota", "Schistosomiasis", "Bilharziasis ", and "Human". Extracted data were analysed qualitatively from the selected articles.

Results

Of the 885 articles retrieved and screened, only 13 (1.47%) met the inclusion criteria and were included in this review. Of the included studies, 6 (46.2%) explored alterations of gut microbiome in schistosome-infected patients, 4 (30.7%) in patients with liver pathologies, and 3 (23.1%) in patients treated with praziquantel. Bacteria from the genera Bacteroides , Faecalibacterium , Blautia and Megasphaera were associated with S . japonicum and S . haematobium infection in school-aged children, whereas infection with S . mansoni rather associated with Klebsiella and Enterobacter . The gut microbiota signature in patient with schistosomiasis-induced liver pathology was reported only for S . japonicum , and the genus Prevotella appeared as a non-invasive biomarker of S . japonicum -associated liver fibrosis. For S . mansoni -infected school-aged children, it further appeared that the treatment outcome following praziquantel administration associated with the abundance in the gut microbiome of bacteria from the classes Fusobacteriales, Rickettsiales and Neisseriales.

Conclusion

The host gut microbiome appears to be a valuable, non-invasive, but still poorly utilized, source of host biomarkers potentially informative for better diagnosing, prognosing and treating schistosomiasis. Further studies are therefore needed to comprehensively define such gut microbial biomarkers of human schistosomiasis and catalyse the informed development of gut microbiome-based tools of schistosomiasis control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeSchistosomiasisHumansPrognosisBacteriaBiomarkersAnimalsAnthelminticsPraziquantelSchistosoma

Substanzen

BiomarkersAnthelminticsPraziquantel

Autor:innen und Institutionen

  • Laboratory of Microbiology, Infectious Diseases and Immunology, Institute of Medical Research and Medicinal Plant Studies (IMPM), Ministry of Scientific Research and Innovation, Yaoundé, Cameroon.
  • Unit of Immunobiology and helminth infections, Laboratory of Molecular Biology and Biotechnology, Institute of Medical Research and Medicinal plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Camer…
  • Laboratory of Parasitology and Ecology, Department of Animal Biology and Physiology, University of Yaoundé 1, Yaoundé, Cameroon.
  • Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
  • Department of Microbiology and Parasitology, University of Bamenda, Bamenda, Cameroon.
  • Africa Health Research Institute, Durban, Kwazulu-Natal, South Africa.

ORCID-Profile: Justin Komguep Nono

Zitieren

APA

Oyono, M. G., Kenmoe, S., Ebogo Belobo, J. T., Mbah Ntepe, L. J., Kameni, M., Kamguia, L. M., Mpotje, T., & Nono, J. K. (2025). Diagnostic, prognostic, and therapeutic potentials of gut microbiome profiling in human schistosomiasis: A comprehensive systematic review. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012844

Vancouver

Oyono MG, Kenmoe S, Ebogo Belobo JT, Mbah Ntepe LJ, Kameni M, Kamguia LM, et al. Diagnostic, prognostic, and therapeutic potentials of gut microbiome profiling in human schistosomiasis: A comprehensive systematic review. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012844

BibTeX
@article{Oyono2025,
  author = {Oyono, Martin Gael and Kenmoe, Sebastien and Ebogo Belobo, Jean Thierry and Mbah Ntepe, Leonel Javeres and Kameni, Mireille and Kamguia, Leonel Meyo and Mpotje, Thabo and Nono, Justin Komguep},
  title = {Diagnostic, prognostic, and therapeutic potentials of gut microbiome profiling in human schistosomiasis: A comprehensive systematic review},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012844}
}
Kostenlos starten →